| 9000310 |
8-methyl Nonanoic Acid
|
|
5963-14-4 |
≥98%
|
|
|
2008-10-10
|
5.763856353591
|
8-methyl-nonanoic-acid
|
Isocapric Acid
|
capsaicin intermediate bacteria growth substrate antimicrobial capsicum bacterial bacterium |
| 10012588 |
A-803467
|
|
944261-79-4 |
≥98%
|
|
|
2009-02-14
|
0.132596685083
|
a-803467
|
|
Nav1.8 sodium channels neuropathic pain inflammatory blockers inhibitors inhibits inhibition TTX-resistance TTX-R |
| 10010118 |
AM1241
|
|
444912-48-5 |
>97%
|
|
|
2007-08-29
|
33.313569060773
|
am1241
|
|
CB1 CB2 cannabinoids receptors agonists antagonists antinociception AM630 AM251 AM-1241 AM 1241 |
| 10006974 |
AM630
|
|
164178-33-0 |
≥98%
|
|
|
2009-02-09
|
20.384806629834
|
am630
|
Iodopravadoline
|
neurochemistry neuroscience cannabinoids CB1 CB2 antagonist inverse agonist antinociception pain receptors |
| 10010088 |
CAY10526
|
|
- |
>98%
|
|
|
2007-09-07
|
600.202143646409
|
cay10526
|
|
mPGES-1 mPGES1 microsomal prostaglandin E2 PGE2 synthase prostanoid modulators inflammatory inflammation pain inhibition inhibitors inhibits expressions |
| 10012565 |
CAY10568
|
|
22913-17-3 |
≥98%
|
|
|
2008-05-28
|
6.248572744014
|
cay10568
|
Santinamide
|
TRPV1 QX314 cationic lidocaine capsaicin pain ion channel anesthetics analgesia nociception CAY10568 |
| 10010032 |
CAY10570
Exclusive |
|
875014-22-5 |
>98%
|
|
✓ |
2008-06-03
|
22.081339779005
|
cay10570
|
|
FAAH fatty acids amides AEA anandamides CB1 inhibitors inhibits inhibition endocannabinoids hydrolases |
| 13164 |
CAY10589
Exclusive |
|
1077626-52-8 |
≥98%
|
|
✓ |
2009-06-23
|
4.758468823994
|
cay10589
|
|
Microsomal prostaglandin E2 synthase-1 mPGES-1 inhibitors cyclooxygenase cyclooxygenase-2 COX-2 PGE2 5-lipoxygenase 5-LO COX-1 leukotrienes LTB4 LTC4 LTD4 LTE4 dual inhibits inhibition inflammation fever pain signaling sagnalling |
| 10010398 |
CB-13
|
|
432047-72-8 |
≥98%
|
|
|
2009-06-30
|
38.221719207020
|
cb-13
|
|
cannabinoids CB1 CB2 central peripheral receptors agonists pains hyperalgesia blocks blocking CB13 CB 13 |
| 13289 |
CB-86
Exclusive New |
|
1150586-64-3 |
≥98%
|
|
✓ |
2010-05-03
|
56.201583793738
|
cb-86
|
|
cannabinoids receptors CB1 CB2 antinociception agonists resorcinol anandamides hybrids CB86 CB 86 partial agonist neural antagonist antinociceptive effects |
| 13218 |
(−)-CP 47,497
|
|
114753-51-4 |
≥98%
|
|
|
2009-04-13
|
23.943369378386
|
-cp-47-497
|
|
cannabinoids analgesia CB1 hypothermia motor deppressant anticonvulsant Δ9-THC analogs activity hypothermic effects |
| 13219 |
(+)-CP 47,497
|
|
134308-14-8 |
≥98%
|
|
|
2009-04-13
|
19.369751946792
|
-cp-47-497
|
|
cannabinoid analgesia analgesic CB1 hypothermia motor depressant anticonvulsant Δ9-THC CBs analogs |
| 16851 |
(±)-CP 47,497
|
|
70434-82-1 |
≥98%
|
|
|
2008-12-10
|
36.372038187255
|
-cp-47-497
|
|
receptors agonist CB1 potent cannabinoid DELTA9-THC Δ9-THC CP47,497 CP-47,497 CP47497 CP-47497 |
| 13216 |
(±)-CP 47,497-C8-homolog
Exclusive |
|
70434-92-3 |
≥98%
|
|
✓ |
2009-04-23
|
28.815182096753
|
-cp-47-497-c8-homolog
|
CAY10596
|
cannabinoids analgesia analgesic CB1 hypothermia motor supressants anticonvulsant Δ9-THC C8 analog CP 47,497-C8 CP47,497-C8 |
| 13608 |
(+)-CP 55,940
New |
|
- |
≥98%
|
|
|
2010-05-20
|
20.889805645634
|
-cp-55-940
|
|
Δ9-THC cannabinoids CB1 CB2 pain analgesic |
| 13241 |
(±)-CP 55,940
Exclusive |
|
83003-12-7 |
≥98%
|
|
✓ |
2009-05-20
|
20.889805645634
|
-cp-55-940
|
|
cannabinoids analgetic pain THC thermal mechanical chemicals receptors CB1 cannabimimetic potent non-selective CP55940 CP-55940
|
| 9000639 |
Docosahexaenoyl Serotonin
Exclusive New |
|
283601-58-1 |
≥98%
|
|
✓ |
2010-05-18
|
0E-12
|
docosahexaenoyl-serotonin
|
|
N-arachidonoyl serotonin AA-5-HT AA-5HT antagonists fatty acids amide hydrolase FAAH transient receptors potential vanilloid-type 1 channels TRPV1 pain capsaicin ethanolamine anandamide AEA |
| 10477 |
EP2 Receptor Polyclonal PE Antibody
New |
|
- |
|
|
|
2010-07-07
|
300.437306629834
|
ep2-receptor-polyclonal-pe-antibody
|
Prostaglandin E2 Receptor 2; PGE2 Receptor 2
|
R-phycoerythrin immunofluorescent FL-2 FL2 FL 2 channels G-protein coupled G protein flow cytometry FC immunofluorescence IF EP1 EP2 EP3 EP4 cAMP smooth muscles mRNA tissues lungs placenta placenta spleen intestines kidneys sensory neurons |
| 10010183 |
Fatty Acid Amide Hydrolase (human recombinant)
|
|
- |
100,000 x g supernatant
|
|
|
2008-11-05
|
54.928239936858
|
fatty-acid-amide-hydrolase-human-recombinant
|
FAAH (human recombinant)
|
FAAHs endocannabinoid AEA cannabinoids 2-AG 2AG proteins FAAH-1 acids amides hydrolases |
| 10011347 |
Glycerophospho-N-Arachidonoyl Ethanolamine
Exclusive |
|
201738-25-2 |
≥97%
|
|
✓ |
2009-03-13
|
23.463167587477
|
glycerophospho-n-arachidonoyl-ethanolamine
|
Glycerophospho-Arachidonoyl Ethanolamide; Glycerophosphoanandamide; GP-NArE
|
anandamides arachidonoyl ethanolamide AEA NAE GDE1 cannabinoids neurotransmitters CB1 CB2 glycerophosphodiesterase 1 NAPE N-Acyl Phosphatidylethanolamide |
| 10224 |
GPR55 Polyclonal Antibody
|
|
- |
|
|
|
2010-01-19
|
52.356819258090
|
gpr55-polyclonal-antibody
|
G Protein-Coupled Receptor 55
|
proteins receptors antibodies western blots WB ICC signals signaling nucleotides THC amino acids blotting immunoblotting immunocytochemistry signalling |
| 10010372 |
GW 842166X
|
|
666260-75-9 |
>98%
|
|
|
2008-05-23
|
11.112279005524
|
gw-842166x
|
|
inflammatory pain arthritis neuropathic hyperalgesia CB2 cannabinoids agonists anandamide receptors neurochemistry |
| 10010410 |
GW 848687X
Exclusive |
|
612831-24-0 |
≥98%
|
|
✓ |
2009-11-25
|
28.537812154696
|
gw-848687x
|
|
Receptors EP1 PGE2 vasoconstriction bronchoconstriction hyperalgesia allodynia gastric protection relief hyperthermia sleep antagonists thromboxanes TP inflammation arthritis pain inflammatory GW848687X GW-848687X |
| 10011038 |
Hemopressin
|
|
- |
|
|
|
2009-08-13
|
58.529090909091
|
hemopressin
|
|
peptides antagonist inhibitors inhibits inhibition hypertension binding asoactive vasoactive |
| 10215 |
IDFP
|
|
615250-02-7 |
≥98%
|
|
|
2009-03-09
|
36.371639042357
|
idfp
|
Isopropyl Dodecylfluorophosphonate
|
CB1 agonist nerve agent serins organophophorus MAGL inhibitors inhibits inhibition FAAH 2-AG 2AG AEA arachidonic acids MGL inhibitor |
| 13169 |
JWH 018
|
|
209414-07-3 |
≥98%
|
|
|
2009-03-12
|
49.692032855579
|
jwh-018
|
|
cannabinoids CB1 CB2 agonists selective receptors WIN 55,212-2 JWH-018 JWH018 |
| 9000851 |
JWH 018 4-hydroxyindole metabolite
Exclusive New |
|
- |
≥98%
|
|
✓ |
2010-09-01
|
0E-12
|
jwh-018-4-hydroxyindole-metabolite
|
|
cannabinoids receptors WIN 55,212-2 WIN55212-2 WIN 552122 WIN552122 WIN 55,2122 WIN55,2122 CB1 CB2 cannabimimetics urine urinary metabolites 1 glucuroconjugate forensics JWH-018 JWH018 209414-07-3 JWH018-metabolite JWH 018-metabolite one CBs M-1 M1 smoking mixtures spices |
| 9000852 |
JWH 018 5-hydroxyindole metabolite
Exclusive New |
|
- |
≥98%
|
|
✓ |
2010-09-01
|
0E-12
|
jwh-018-5-hydroxyindole-metabolite
|
|
cannabinoids receptors WIN 55,212-2 WIN55212-2 WIN 552122 WIN552122 WIN 55,2122 WIN55,2122 CB1 CB2 cannabimimetics urine urinary metabolite glucuroconjugate forensics JWH-018 JWH018 209414-07-3 foresnsic science pain nueroscience JWH-018-metabolite JWH018-metabolite JWH 018-metabolite two 2 smoking mixtures spices CBS M-2 M2 |
| 9000853 |
JWH 018 6-hydroxyindole metabolite
Exclusive New |
|
- |
|
|
✓ |
2010-09-01
|
0E-12
|
jwh-018-6-hydroxyindole-metabolite
|
|
cannabinoids receptors WIN 55,212-2 WIN55212-2 WIN 552122 WIN552122 WIN 55,2122 WIN55,2122 CB1 CB2 cannabimimetics urine urinary metabolites glucuroconjugate forensics JWH-018 JWH018 209414-07-3 foresnsic science pain nueroscience JWH-018-metabolite JWH018-metabolite JWH 018-metabolite three 3 M-3 M3 CBs smoking mixture spices |
| 9000854 |
JWH 018 7-hydroxyindole metabolite
Exclusive New |
|
- |
≥98%
|
|
✓ |
2010-09-01
|
0E-12
|
jwh-018-7-hydroxyindole-metabolite
|
|
cannabinoids receptors WIN 55,212-2 WIN55212-2 WIN 552122 WIN552122 WIN 55,2122 WIN55,2122 CB1 CB2 cannabimimetics urine urinary metabolite glucuroconjugate forensics JWH-018 JWH018 209414-07-3 foresnsic science pain nueroscience JWH-018-metabolite JWH018-metabolite JWH 018-metabolite four 4 M4 M-4 smoking mixtures spices |
| 13824 |
JWH 018-d9
New |
|
- |
≥99% deuterated product
|
|
|
2010-06-21
|
0E-12
|
jwh-018-d9
|
|
cannabinoids CB1 CB2 agonists selective receptors WIN 55,212-2 JWH-018 JWH018 deuterateds deuteriums CBs cannabinoids LC-MS LC/MS GC-MS GC/MS mass spectrometry MS |
| 9000855 |
JWH 018 N-(5-hydroxypentyl) metabolite
Exclusive New |
|
- |
≥98%
|
|
✓ |
2010-09-01
|
0E-12
|
jwh-018-n-5-hydroxypentyl-metabolite
|
|
cannabinoids receptors WIN 55,212-2 WIN55212-2 WIN 552122 WIN552122 WIN 55,2122 WIN55,2122 CB1 CB2 cannabimimetics urine urinary metabolite glucuroconjugate forensics JWH-018 JWH018 209414-07-3 foresnsic science pain nueroscience JWH-018-metabolite JWH018-metabolite JWH 018-metabolite five 5 CBs M-5 M5 smoking mixtures spices |
| 9000856 |
JWH 018 N-pentanoic acid metabolite
Exclusive New |
|
- |
≥98%
|
|
✓ |
2010-09-01
|
0E-12
|
jwh-018-n-pentanoic-acid-metabolite
|
|
cannabinoids receptors WIN 55,212-2 WIN55212-2 WIN 552122 WIN552122 WIN 55,2122 WIN55,2122 CB1 CB2 cannabimimetics urine urinary metabolite glucuroconjugate forensics JWH-018 JWH018 209414-07-3 science pain nueroscience JWH-018-metabolite JWH018-metabolite JWH 018-metabolite 6 six CBs M6 M-6 smoking mixtures spices |
| 13633 |
JWH 019
|
|
209414-08-4 |
≥98%
|
|
|
2010-01-14
|
67.298560318265
|
jwh-019
|
|
cannabinoids CB1 CB2 receptors THC JWH-019 JWH019 Δ9-THC Δ9-tetrahydrocannabinols delta 9 tetrahydrocannabinol cannabinmimetic indoles |
| 13170 |
JWH 073
|
|
208987-48-8 |
≥97%
|
|
|
2009-03-02
|
51.317119181546
|
jwh-073
|
|
cannabinoid CB1 CB2 agonist selective receptors WN55212-2 WIN552122 WIN 552122 WIN 55212-2 jwh073 |
| 9000861 |
JWH 073 4-hydroxyindole metabolite
Exclusive New |
|
- |
≥98%
|
|
✓ |
2010-09-01
|
0E-12
|
jwh-073-4-hydroxyindole-metabolite
|
|
cannabinoids receptors WIN 55,212-2 CB1 CB2 cannabimimetics urine urinary metabolites forensics JWH 073 Metabolite 1 JWH-073 JWH073 M-1 CBs smoking mixtures spices |
| 9000862 |
JWH 073 5-hydroxyindole metabolite
Exclusive New |
|
- |
≥98%
|
|
✓ |
2010-09-01
|
0E-12
|
jwh-073-5-hydroxyindole-metabolite
|
|
cannabinoids receptors WIN 55,212-2 CB1 CB2 cannabimimetics urine urinary metabolites glucuroconjugate forensics JWH 073 Metabolite 2 JWH-073 JWH073 CBs M-2 agonists smoking mixtures spices |
| 9000863 |
JWH 073 6-hydroxyindole metabolite
Exclusive New |
|
- |
≥95%
|
|
✓ |
2010-09-01
|
0E-12
|
jwh-073-6-hydroxyindole-metabolite
|
|
cannabinoids receptors WIN 55,212-2 CB1 CB2 cannabimimetics urine urinary metabolites forensics JWH 073 Metabolite 3 JWH-073 JWH073 M-3 CBs smoking mixtures spices |
| 9000864 |
JWH 073 7-hydroxyindole metabolite
Exclusive New |
|
- |
98%
|
|
✓ |
2010-09-01
|
0E-12
|
jwh-073-7-hydroxyindole-metabolite
|
|
cannabinoids receptors WIN 55,212-2 CB1 CB2 cannabimimetics urine urinary metabolites forensics JWH 073 Metabolite 4 JWH-073 CBs JWH073 M-4 mixtures smoking spices |
| 9000868 |
JWH 073-d7
New |
|
- |
≥99% deuterated product
|
|
|
2010-08-10
|
0E-12
|
jwh-073-d7
|
|
deuterateds deuteriums CBs cannabinoids LC-MS LC/MS GC-MS GC/MS mass spectrometry MS standards JWH-073 JWHs JWH073 JWH73 JWH-73 JWH 73 cannabinoids CB1 receptors CB2 peripheral central |
| 9000865 |
JWH 073 N-(5-hydroxybutyl) metabolite
Exclusive New |
|
- |
≥98%
|
|
✓ |
2010-09-01
|
0E-12
|
jwh-073-n-5-hydroxybutyl-metabolite
|
|
cannabinoids receptors WIN 55,212-2 CB1 CB2 cannabimimetics urine urinary metabolites glucuroconjugate forensics JWH 073 Metabolite 5 JWH-073 smoking JWH073 CBs mixtures spices M-5 |
| 9000866 |
JWH 073 N-butanoic acid metabolite
Exclusive New |
|
- |
≥98%
|
|
✓ |
2010-09-01
|
0E-12
|
jwh-073-n-butanoic-acid-metabolite
|
|
cannabinoids receptors WIN 55,212-2 CB1 CB2 cannabimimetics urine urinary metabolites glucuroconjugates forensics JWH 073 Metabolite 6 JWH-073 CBs JWH073 M-6 smoking mixtures spices |
| 13634 |
JWH 250
|
|
864445-43-2 |
≥98%
|
|
|
2010-01-14
|
75.255792964475
|
jwh-250
|
|
cannabinoids CB1 CB2 receptors THC JWH-250 JWH250 Δ9-THC Δ9-tetrahydrocannabinols delta 9 tetrahydrocannabinols indoles |
| 10578 |
JWH 251
New |
|
864445-39-6 |
≥98%
|
|
|
2010-08-20
|
11.685128913443
|
jwh-251
|
|
cannabinoids receptors JWHs JWH-251 JWH251 WIN55212-2 WIN 55212-2 CB1 CB2 cannabimimetics urine forensics |
| 13158 |
JZL 184
Exclusive |
|
1101854-58-3 |
≥97%
|
|
✓ |
2009-01-26
|
159.274762430939
|
jzl-184
|
|
2-AG 2AG MAGL inhibitors inhibits inhibition endocannabinoid pains analgesia MGL inhibitor JZL184 JZL-184 |
| 13668 |
JZL 195
Exclusive |
|
- |
≥98%
|
|
✓ |
2010-02-10
|
119.371514769074
|
jzl-195
|
|
fatty acid amide hydrolase FAAH monoacylglycerol lipase MAGL endocannabinoids arachidonoyl ethanolamide AEA 2-arachidonoylglycerol 2-AG inibitors inhibition inhibits PF-3845 PF 3845 PF3845 JZL195 JZL-195 JZL184 antinociception pain catalepsy hypomotility CB1 2AG |
| 10009280 |
L-759,633
|
|
174627-50-0 |
>98%
|
|
|
2007-09-13
|
11.112279005524
|
l-759-633
|
|
L759633 cannabinoids receptors agonists CB1 CB2 endocrinology neurochemistry |
| 10007712 |
L-902,688
Exclusive New |
|
634193-54-7 |
≥98%
|
|
✓ |
2010-05-07
|
0E-12
|
l-902-688
|
|
PGE2 bones growth EP4 agonists hyperalgesia vasodialation |
| 9000326 |
Linoleoyl Glycine
|
|
2764-03-6 |
≥98%
|
|
|
2008-10-29
|
4.611809392265
|
linoleoyl-glycine
|
N-Linoleoyl Glycine; LinGly; Glycine Linoleamide
|
arachidonyl glycine fatty acids AEA FAAH inhibits inhibitor inhibition anandamide homologs |
| 10004184 |
NESS 0327
Exclusive |
|
494844-07-4 |
>98%
|
|
✓ |
2008-05-27
|
35.890121546960
|
ness-0327
|
|
neurochemistry neuroscience cannabinoids antagonist CB1 CB2 SR 141716A rimonabant WIN 55212-5 pain obesity |
| 10007697 |
N-Palmitoyl Dopamine
|
|
136181-87-8 |
>98%
|
|
|
2005-11-23
|
4.826464088398
|
n-palmitoyl-dopamine
|
PALDA
|
N-acyls fatty anologs N-araachidonoyl NADA N-oleoyl ODA bovine brains amides palmitic acids hybrids anandamides neurotransmitter pathways inactive vanilloid receptors 1 VR1 ligands hyperalgesics nocifensives responses in vivo entourage effects neurochemistry |
| 10009020 |
N-Palmitoyl Glycine
|
|
2441-41-0 |
≥98%
|
|
|
2009-12-01
|
4.937348066298
|
n-palmitoyl-glycine
|
N-Hexadecanoyl-Glycine; PalGly
|
pain inflammation AEA anandamides DRG nociception calcium influx arachidonoyl amides glycines |
| 10009195 |
O-2545 (hydrochloride)
|
|
- |
>98%
|
|
|
2007-07-12
|
1.392265193370
|
o-2545-hydrochloride
|
|
cannabinoids water soluble agonists receptors CB1 CB2 lipophilic surfactants 874745-42-3 murine models intravenously IV 02545 intracerebroventricularly endocrinology neurochemistry |
| 10010547 |
O-Arachidonoyl Glycidol
Exclusive |
|
439146-24-4 |
>98%
|
|
✓ |
2008-03-31
|
43.893867403314
|
o-arachidonoyl-glycidol
|
|
2-AG 2-arachidonoyl glycerol 2-oleoylglycerol N-arachidonoylethanolamine anandamide AEA FAAH endocannabinoid obesity pain neurodegenerative diseases monoacylglycerol lipase inhibits inhibitors inhibitions MAGL MGL |
| 9000629 |
Oleoyl Serotonin
Exclusive New |
|
1002100-44-8 |
≥98%
|
|
✓ |
2010-05-18
|
0E-12
|
oleoyl-serotonin
|
|
N-arachidonoyl serotonin AA-5-HT AA-5HT antagonists fatty acids amide hydrolase FAAH transient receptors potential vanilloid-type 1 channels TRPV1 pain capsaicin ethanolamine anandamide AEA |
| 9000630 |
Palmitoyl Serotonin
Exclusive New |
|
212707-51-2 |
≥98%
|
|
✓ |
2010-05-18
|
0E-12
|
palmitoyl-serotonin
|
|
N-arachidonoyl serotonin AA-5-HT AA-5HT antagonists fatty acids amide hydrolase FAAH transient receptors potential vanilloid-type 1 channels TRPV1 pain capsaicin ethanolamine anandamide AEA |
| 13279 |
PF-3845
|
|
- |
≥98%
|
|
|
2010-01-27
|
74.697707182320
|
pf-3845
|
|
fatty acids hydrolase FAAH N-acyl ethanolamines NAEs endocannabinoids N-arachidonoyl ethanolamine anandamide AEA inhibitors inhibits inflammation pain PF3845 PF 3845 |
| 10010907 |
PF-622
|
|
898235-65-9 |
>98%
|
|
|
2008-03-26
|
9.965125371865
|
pf-622
|
|
FAAH inhibitors inhibits inhibition cannabinoids depression anxiety inflammation pain fatty acids amides hydrolases neurochemistry |
| 10010908 |
PF-750
|
|
959151-50-9 |
>98%
|
|
|
2008-03-25
|
17.691780437896
|
pf-750
|
|
FAAH inhibitors inhibits inhibition cannabinoids depression anxiety inflammation pain neurochemistry |
| 13368 |
Piroxicam
|
|
36322-90-4 |
≥95%
|
|
|
2010-01-06
|
18.259891376272
|
piroxicam
|
NSC 666076; Larapam; Feldene
|
inflammation NSAIDs inhibitors cyclooxygenases COX-1 COX-2 analgesic pain arthritis cancers Artrooxicam Baxo Bruxicam CP 16171 Geldene Neoxicam Reudene Roxicam Roxiden Sasulen Solocalm Uphaxicam Zunden inhibition inhibited inflammatory |
| 13621 |
Pristimerin
Exclusive New |
|
1258-84-0 |
≥98%
|
|
✓ |
2010-03-08
|
143.627627566680
|
pristimerin
|
Celestrol methyl ester; NSC 99281
|
monoacylglycerol lipases MAGLs monoglycerol MGLs cannabinoids 2-arachidonoyl glycerol 2-AG inhibitor 2-Picenecarboxylic acids |
| 10007684 |
Prostaglandin D Synthase (lipocalin-type; human) EIA Kit
Exclusive |
|
- |
|
|
✓ |
2008-06-09
|
11.181801954951
|
prostaglandin-d-synthase-lipocalin-type-human-eia-kit
|
Lipocalin-PGDS ELISA Kit; L-PGDS EIA Kit
|
EIAs ELISAs Assays sandwich immunometric homodimer glycosylation catalyzes prostaglandins PGH2 PGD2 carrier proteins lipid-like molecules neurochemistry retinoids thyroid hormones body fluids cerebrospinal seminal plasma PTGDS beta-trace b-trace .beta.-trace betatrace btrace lpgds l-pgds assays |
| 10384 |
Prostaglandin E2 isopropyl ester
Exclusive New |
|
71845-66-4 |
≥98%
|
|
✓ |
2010-06-07
|
0E-12
|
prostaglandin-e2-isopropyl-ester
|
|
PGE2 inflammation fertility parturition immunology reproductive biology pain prostaglandins E2 lipophilic |
| 10007939 |
Prostaglandin E Synthase-1 (microsomal) (human recombinant)
|
|
- |
16,000 x g supernatant
|
|
|
2009-03-15
|
43.443563535911
|
prostaglandin-e-synthase-1-microsomal-human-recombinant
|
MGST1-L1; mPGE Synthase-1; PIG12; Prostaglandin H/E Isomerase; Membrane-Associated PGES-1
|
enzymes proteins PGs prostaglandins catalyzes conversion PGH2 PGE2 membrane-associated eicosanoids glutathiones metabolisms MAPEG expression proinflammatory stimuli stimulus IL-1.beta. IL-1b interleukins glucocorticoids synovial tissues primary synoviocytes rheumatiod arthritis fever onset drugs anti-inflammatory therapy therapies E. coli mPGES mPGES-1 mPGES1 |
| 10011032 |
QX-314 (bromide)
|
|
24003-58-5 |
≥98%
|
|
|
2009-02-03
|
0.132596685083
|
qx-314-bromide
|
|
lidocaine local anesthetic TRPV1 sodium channel blocker pain nociceptor capsaicin |
| 10491 |
(R)-AM1241
Exclusive New |
|
444912-51-0 |
≥98%
|
|
✓ |
2010-05-27
|
5.797237569061
|
-r-am1241
|
(+)-AM1241
|
cannabinoids CB2 receptors CB1 agonists inverse agonists antinociception pains SR144528 rimonabant CBs |
| 10490 |
(S)-AM1241
Exclusive New |
|
444912-53-2 |
≥98%
|
|
✓ |
2010-05-27
|
5.797237569061
|
-s-am1241
|
(-)-AM1241
|
cannabinoids CB2 receptors CB1 agonists inverse agonist antinociception pains SR144528 rimonabant CBs |
| 10011561 |
SC-51089
|
|
146033-02-5 |
≥95%
|
|
|
2010-02-02
|
78.715547882136
|
sc-51089
|
CID132748
|
prostaglandins E2 PGE2 receptors EP1 pain antagonists analgesia glioma cells cancers tumors growth neuroprotection neurons oxidative stress SC51089 SC 51089 PGs |
| 10010744 |
SC-51322
New |
|
146032-79-3 |
>98%
|
|
|
2010-03-09
|
116.778152240638
|
sc-51322
|
|
SC51322 SC 51322 prostaglandins E2 PGE2 receptors EP1 pain vasorelaxation inflammation PGs inflammatory signaling signalling antagonist |
| 10012555 |
Sodium Hydrogen Sulfide (hydrate)
|
|
207683-19-0 |
≥65%
|
|
|
2009-09-03
|
7.244880294659
|
sodium-hydrogen-sulfide-hydrate
|
Sodium Hydrosulfide; NSC 158264; NaHS
|
hydrogen sulfide H2S donor inflammation oxidative stress cardiocascular neurological neurons pulmonary leukocytes neutrophils pain 1310-76-5 64568-18-9 111883-06-8 16721-80-5 |
| 9000491 |
SR 144528
Exclusive |
|
192703-06-3 |
≥98%
|
|
✓ |
2009-08-05
|
61.538370165745
|
sr-144528
|
|
antagonist CB1 CB2 cannabinoids receptors inverse agonist inflammation leukocytes CP 55940 CP55940 55,940 CP55,940 pain initiation suppression immune activation sr144528 CBs |
| 9000631 |
Stearoyl Serotonin
Exclusive New |
|
67964-87-8 |
≥98%
|
|
✓ |
2010-05-18
|
0E-12
|
stearoyl-serotonin
|
|
N-arachidonoyl serotonin AA-5-HT AA-5HT antagonists fatty acids amide hydrolase FAAH transient receptors potential vanilloid-type 1 channels TRPV1 pain capsaicin ethanolamine anandamide AEA |
| 13830 |
Synthetic Cannabinoid HPLC Mixture
New |
|
- |
≥95% for each compound
|
|
|
2010-05-13
|
0E-12
|
synthetic-cannabinoid-hplc-mixture
|
|
cannabinoids CBs endocannabinoids cannabidiols CP-47,497 cp 47,497 47,497-c8-homolog CP-47,497-C8 homolog analog CP-55,940 cp47,497 cp55,940 cp 55,940 HU-331 HU331 HU 331 HU308 HU 308 HU-308 JWH-015 jwh015 jwh 015 jwh 018 jwh018JWH-018 JWH-200 jwh200 jwh 200 jwh 250 jwh250 JWH-019 Win-55212-2 Jwh-250 win 55212-2 win55212 2 synthetic spices mixes |
| 13665 |
YS121
Exclusive New |
|
916482-17-2 |
≥98%
|
|
✓ |
2010-04-02
|
15.062066298342
|
ys121
|
|
Microsomal Prostaglandin E2 Synthase-1 mPGES-1 cyclooxygenase-2 COX-2 PGE2 inflammation fever pain 5-Lipoxygenase 5-LO leukotrienes LTs inhibitors LTB4 cyclooxygenase-1 COX-1 LTC4 LTD4 LTE4 inhibition inhibits PGs YS 121 YS-121 |
| 13271 |
ZLJ-6
Exclusive |
|
1051931-39-5 |
≥98%
|
|
✓ |
2009-06-17
|
0.280110497238
|
zlj-6
|
|
inhibitors cyclooxygenase COX-1 COX-2 5-lipoxygenase 5-LO inflammation pain ZLJ6 ZLJ 6 |